Search

A lightning current measurement method using a Rogowski coil based on an integral circuit with low-frequency attenuation feedback was proposed to address the issue of low-frequency distortion in the measurement of lightning currents on transmission lines using Rogowski coils. Firstly, the causes of low-frequency distortion in lightning current measurements using Rogowski coils were analyzed from the perspective of frequency domains. On this basis, an integration correction optimization circuit with a low-frequency attenuation feedback network was designed to correct the low-frequency distortion. The optimized integration circuit can also reduce the impact of low-frequency noise and the DC bias of the operational amplifier (op-amp) on the integration circuit due to the high low-frequency gain. Additionally, a high-pass filtering and voltage-divided sampling circuit has been added to ensure the normal operation of the integrator and improve the measurement range of the measurement system. Then, according to the relationship between the amplitude–frequency characteristics of the measurement system and the parameters of each component, the appropriate types of components and op-amp were selected to expand the measurement bandwidth. Finally, a simulation verification was conducted, and the simulation results show that this measurement method can effectively expand the lower measurement frequency limit to 20 Hz, correct the low-frequency distortion caused by Rogowski coils measuring lightning currents on transmission lines, and accurately restore the measured lightning current waveform. [ABSTRACT FROM AUTHOR]

Introduction: Lysinuric protein intolerance (LPI) is a rare genetic disorder caused by mutations in the solute carrier family 7A member 7 (SLC7A7) gene. Case presentation: We presented two siblings with LPI, carrying novel mutations of c.776delT (p.L259Rfs*18) and c.155G>T (p.G52V) in SLC7A7. The younger sibling, preferring protein‐rich foods, showed severe symptoms, including alveolar proteinosis, macrophage activation syndrome, severe diarrhea, and disturbance of consciousness with involuntary movements. In contrast, the elder sibling only had mild symptoms, likely due to aversion to protein‐rich food since toddler age. Conclusion: LPI is a congenital genetic metabolic disease with multi‐system involvement. Initiating appropriate protein‐restricted diet therapy as soon as possible could help prevent the progression of LPI. [ABSTRACT FROM AUTHOR]

The low energy density, safety concerns, and high cost associated with conventional lithium‐ion batteries pose challenges in meeting the growing demands of emerging applications. While lithiumsulfur batteries (LSBs) offer high specific capacity, their commercial viability is hindered by the prevalent issue of shuttle effects. Furthermore, the potential of solid‐state lithium batteries is constrained by the suboptimal ionic conductivity and significant interphase problems. High‐entropy materials (HEMs) have emerged as a strategic approach for the development of innovative materials possessing exceptional properties. In recent times, some studies have been undertaken to explore the potential of HEMs in lithium‐based rechargeable batteries, showcasing their favorable characteristics. This work provides a comprehensive overview of the impact of various factors associated with HEM materials, encompassing elements, structure, and morphology, on the reversibility of reactions and cycling stability. This work also presents an analysis of the effects of elements and morphology on the properties of HEMs in LSBs, which can trap soluble lithium polysulfides and enhance reaction kinetics. Additionally, the work provides an overview of high‐entropy electrolytes, including both solid‐state and non‐aqueous liquid electrolytes. Furthermore, the research outlines future research directions aimed at investigating more efficient HEMs and enhancing the overall performance of lithium‐based rechargeable batteries. [ABSTRACT FROM AUTHOR]

Objectives: This meta-analysis was performed to compare polymyxin monotherapy and polymyxin-based combination therapy for carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections. Methods: We conducted searches on MEDLINE, Embase and Cochrane Collaborative database for both observational studies and randomised controlled trials (RCTs) comparing polymyxin monotherapy with polymyxin-based combination therapy in patients with CR-KP infection. The primary outcome was mortality. We divided all included studies into several groups according to different combination-combination and different infection types. The odds ratio (OR) and 95% confidence intervals (CI) were calculated for outcome analysis. Results: Ten studies with 481 patients were included. Polymyxin monotherapy was associated with higher mortality than polymyxin-based combination therapy in treatment of CR-KP bloodstream infections (BSI) (OR 1.93, 95% CI 1.14–3.27, P = 0.01) and ventilator-associated pneumonia (VAP)/hospital-acquired pneumonia (HAP) (OR 3.82, 95% CI 1.15–12.71, P = 0.03). In subgroup analysis of different combinations, mortality was significantly higher with polymyxin monotherapy compared with combination therapy with tigecycline (OR 1.88, 95% CI 1.05–3.37, P = 0.03), or with cabapenem (OR 3.11, 95% CI 1.25–7.74, P = 0.01), but no differences were found in combinations with aminoglycosides (OR 1.29, 95% CI 0.72–2.29, P = 0.38). Three-drug combination therapy including polymyxin was also associated with significant survival benefit (OR 3.86, 95% CI 1.60–9.32, P = 0.003). Conclusions: Polymyxin-based combination therapy provides significant survival benefit in treatment of CR-KP, which appears to be more pronounced when a carbapenem or tigecycline is included in the regimen.